Login to Your Account

Financings Roundup

Monday, December 27, 2010
Momenta Pharmaceuticals Inc., of Cambridge, Mass., said underwriters UBS Investment Bank, Cowen & Co. and Canaccord Genuity exercised their overallotment option related to the biotech's recent public stock offering, purchasing an additional 218,647 shares for $14.35 each in addition to the 4 million shares already sold.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription